Scientific publications

Hyperangulated versus Macintosh blades for intubation with videolaryngoscopy in ICU: the randomised multicentre INVIBLADE-ICU trial study protocol. Scientific Publication

Sep 5, 2024 | Magazine: BMJ Open

Manuel Taboada  1 , Ana Estany-Gestal  2 , Jorge Fernández  3 , Olalla Vazquez  4 , Azucena Pajares  5 , Fernando Ramasco  6 , Sara Martínez  7 , Irene Vallejo  8 , Ana Pérez  9 , Pablo Rama-Maceiras  10 , María Bermúdez  11 , Mercedes Power  12 , Raquel García-Álvarez  13 , Inmaculada Fernández-Villa  14 , Jose Luis Aguilera  15 , Marta Carrió  16 , Rafael Cabadas  17 , Anxo Rubín  18 , Mónica Mercedes Williams  19 , Raquel Fernández-García  20 , Angel Becerra  21 , Marta Giné  22 , Francisco Javier García  23 , María Cristina Iglesias  24 , Rosaura María Santamarina  25 , Sara Del Valle  26 , Luisa María Charco  27 , María Concepción Alonso  28 , Inés María Rodríguez  29 , Marina Varela  30 , Jose Ignacio Hermoso  31 , Marc Vives  32 , Teresa Cabaleiro  33


Introduction: Compared with the operating room, tracheal intubations in the intensive care unit (ICU) are associated with worsened glottic view, decreased first-time success rate and increase in the technical difficulty of intubation and incidence of complications. Videolaryngoscopes (VLs) have been proposed to improve airway management, and while recent studies have confirmed that VLs improve intubation conditions in this patient population, there remains a lack of clarity regarding the selection between a standard Macintosh blade or a hyperangulated one, to determine which yields the best outcomes. The purpose of this study was to compare successful intubation on the first attempt with the Macintosh VL versus the hyperangulated VL during tracheal intubation in ICU patients. We hypothesise that tracheal intubation using the hyperangulated VL will improve the frequency of successful intubation on the first attempt.

Methods and analysis: The INtubation VIdeolaryngoscopy BLADE-ICU trial is a prospective, multicentre, open-label, interventional, randomised, controlled superiority study conducted in 29 ICUs in Spain. Patients will be randomly assigned in a 1:1 ratio to undergo intubation using a Macintosh VL (control group) or a hyperangulated VL (experimental group) for the first intubation attempt. The primary outcome is successful intubation on the first attempt. The secondary outcomes include the time to intubation, attempts for successful intubation, laryngoscopic vision assessed with the modified Cormack-Lehane scale, the need for adjuvant airway devices for intubation, difficulty assessed by the anaesthesiologist and complications during tracheal intubation. Enrolment began on 1 May 2024 and is expected to be completed in 2025.

Ethics and dissemination: The study protocol was approved on 29 February 2024, by the Ethics Committee of Galicia (CEImG, code No. 2024-031).The results will be submitted for publication in a peer-reviewed journal.

Trial registration number: NCT06322719.

CITATION  BMJ Open. 2024 Sep 5;14(9):e086691. doi: 10.1136/bmjopen-2024-086691.